Harbor Capital Advisors, Inc. 89bio, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in 89bio, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 217,752 shares of ETNB stock, worth $1.97 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
217,752
Previous 314,772
30.82%
Holding current value
$1.97 Million
Previous $2.29 Million
6.56%
% of portfolio
0.09%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding ETNB
# of Institutions
212Shares Held
162MCall Options Held
289KPut Options Held
1.6M-
Janus Henderson Group PLC London, X020.8MShares$188 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$180 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$128 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$85.9 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$74.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $420M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...